Global Proton Pump Inhibitors Market - Growth, Trends, and Forecasts 2017 - 2022

  • ID: 4388604
  • Report
  • Region: Global
  • 211 pages
  • Mordor Intelligence
1 of 4
The global proton pump inhibitors market accounted for USD XX million in 2015 and is expected to reach USD XX million in 2016. The market is expected to reach USD XX million by 2021, growing at a CAGR of XX% during the forecast period.

Global Proton Pump Inhibitors Market-Market Dynamics

The report details several factor driving and restraining the market. Some of these are listed below.

Drivers

Prevalence of Gastroesophageal Reflux Disease (GERD)

Increasing shift from prescription drugs to over-the-counter products

Increasing new products

Utilization of advanced drug delivery systems

Increasing prevalence of peptic ulcer and gastrointestinal disorders

Restraints

Increasing generic drugs in the market are turning out to be restraints for the market.

The market has been segmented based on drugs and includes the market for Pantoprazole, Omeprazole, Lansoprazole, Esomeprazole, Rabeprazole, Dexlansoprazole and others. The market has been geographically segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. North America has been subdivided into the USA, Canada, and Mexico. The market in Europe has been subdivided into the UK, Germany, France, Italy, Spain, and Rest of Europe. The market in Asia-Pacific has been subdivided into Japan, China, India, South Korea, Australia & New Zealand, and Rest of Asia-Pacific. The Middle East and Africa market has been subdivided into GCC countries, South Africa, and Rest of the Middle East and Africa. South America has been segmented into Brazil, Argentina and Rest of South America.

North America accounted for the largest market value; however, the Asia-Pacific market is expected to grow at a higher CAGR during the forecast period. The utilization of advanced drug delivery systems and bringing new products is always an opportunity for the market. Despite the fact that the market is flooded with many gastrointestinal products, there is a large patient pool with acidity problems and there is a need for a curative drug.

Major Companies in the Sector Include:

This Report Offers:

Market analysis for the global proton pump inhibitors market, with region-specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the global proton pump inhibitors market.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Study deliverables
1.2 Market definition
1.3 General study assumptions
1.4 Report description
2. Research methodology
2.1 Introduction
2.2 Analysis methodology
2.3 Study timeline
2.4 Study phases
2.4.1 Secondary research
2.4.2 Discussion guide
2.4.3 Market engineering & econometric model
2.4.4 Expert validation
3. Executive summary
4. Key inferences
5. Market overview and industry trends
5.1 Current market scenario
5.2 Porter's five forces
5.2.1 Bargaining power of suppliers
5.2.2 Bargaining power of consumers
5.2.3 Threat to new entrants
5.2.4 Threat to substitute products and services
5.2.5 Competitive rivalry within the industry
6. Market drivers, restraints, opportunities, and challenges analysis
6.1 Market drivers
6.1.1 Increasing trends in Rx to OTC
6.1.2 Increasing prevalence of peptic ulcers
6.2 Market restraints
6.2.1 Increasing generic products
6.3 Market opportunities
6.4 Market challenges
7. Market segmentation by drugs
7.1 Omeprazole
7.2 Pantoprazole
7.3 Lansoprazole
7.4 Esomeprazole
7.5 Rabeprazole
7.6 Dexlansoprazole
7.7 Others
8. Market segmentation by geography
8.1 North America
8.1.1 USA
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 UK
8.2.2 Germany
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Scandinavia
8.2.7 BENELUX
8.2.8 Rest of Europe
8.3 Asia-Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 South Korea
8.3.5 Australia & New Zealand
8.3.6 Rest of Asia-Pacific
8.4 Middle East and Africa
8.4.1 GCC
8.4.2 South Africa
8.4.3 Rest of the Middle East & Africa
8.5 South America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Rest of South America
9. Competitive landscape
9.1 Mergers and acquisitions
9.2 New product launches
9.3 Agreements, partnerships, and collaboration
10. Key vendors
10.1 Takeda Pharmaceuticals
10.2 Janssen
10.3 AstraZeneca
10.4 Santarus
10.5 Pfizer
10.6 Wyeth
10.7 Eli Lilly
10.8 Eisai
10.9 Cadila Pharmaceuticals
10.10 GlaxoSmithKline
10.11 Daewoong Pharmaceutical
11. Analyst outlook for investment opportunity
12. Future outlook of the market

List of Tables

Table 1: Global Proton Pump inhibitor market (USD million) (2016 -2021)
Table 2: Global Proton Pump inhibitor market - Segmentation by region (USD million) (2017 - 2022)
Table 3: Global Proton Pump Inhibitor Market - Omeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 4: Global Proton Pump Inhibitor Market - Pantoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 5: Global Proton Pump Inhibitor Market - Esomeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 6: Global Proton Pump Inhibitor Market - Lansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 7: Global Proton Pump Inhibitor Market - Rabeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 8: Global Proton Pump Inhibitor Market - Dexlansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 9: Global Proton Pump Inhibitor Market - Other PPIs Market - Segmentation By Region (USD million) (2017 - 2022)
Table 10: Asia-Pacific Proton Pump inhibitor market (USD million) (2016 -2021)
Table 11: Asia-Pacific Proton Pump inhibitor market - Segmentation by region (USD million) (2017 - 2022)
Table 12: Asia-Pacific Proton Pump Inhibitor Market - Omeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 13: Asia-Pacific Proton Pump Inhibitor Market - Pantoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 14: Asia-Pacific Proton Pump Inhibitor Market - Esomeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 15: Asia-Pacific Proton Pump Inhibitor Market - Lansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 16: Asia-Pacific Proton Pump Inhibitor Market - Rabeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 17: Asia-Pacific Proton Pump Inhibitor Market - Dexlansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 18: Asia-Pacific Proton Pump Inhibitor Market - Other PPIs Market - Segmentation By Region (USD million) (2017 - 2022)
Table 19: Europe Proton Pump inhibitor market (USD million) (2016 -2021)
Table 20: Europe Proton Pump inhibitor market - Segmentation by region (USD million) (2017 - 2022)
Table 21: Europe Proton Pump Inhibitor Market - Omeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 22: Europe Proton Pump Inhibitor Market - Pantoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 23: Europe Proton Pump Inhibitor Market - Esomeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 24: Europe Proton Pump Inhibitor Market - Lansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 25: Europe Proton Pump Inhibitor Market - Rabeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 26: Europe Proton Pump Inhibitor Market - Dexlansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 27: Europe Proton Pump Inhibitor Market - Other PPIs Market - Segmentation By Region (USD million) (2017 - 2022)
Table 28: Middle East and Africa Proton Pump inhibitor market (USD million) (2016 -2021)
Table 29: Middle East and Africa Proton Pump inhibitor market - Segmentation by region (USD million) (2017 - 2022)
Table 30: Middle East and Africa Proton Pump Inhibitor Market - Omeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 31: Middle East and Africa Proton Pump Inhibitor Market - Pantoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 32: Middle East and Africa Proton Pump Inhibitor Market - Esomeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 33: Middle East and Africa Proton Pump Inhibitor Market - Lansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 34: Middle East and Africa Proton Pump Inhibitor Market - Rabeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 35: Middle East and Africa Proton Pump Inhibitor Market - Dexlansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 36: Middle East and Africa Proton Pump Inhibitor Market - Other PPIs Market - Segmentation By Region (USD million) (2017 - 2022)
Table 37: South America Proton Pump inhibitor market (USD million) (2016 -2021)
Table 38: South America Proton Pump inhibitor market - Segmentation by region (USD million) (2017 - 2022)
Table 39: South America Proton Pump Inhibitor Market - Omeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 40: South America Proton Pump Inhibitor Market - Pantoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 41: South America Proton Pump Inhibitor Market - Esomeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 42: South America Proton Pump Inhibitor Market - Lansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 43: South America Proton Pump Inhibitor Market - Rabeprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 44: South America Proton Pump Inhibitor Market - Dexlansoprazole Market - Segmentation By Region (USD million) (2017 - 2022)
Table 45: South America Proton Pump Inhibitor Market - Other PPIs Market - Segmentation By Region (USD million) (2017 - 2022)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll